Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
476
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
16 Feb 2016 00:59
2016 Major IPOs Pipeline in Korea - Part II
In our previous report - 2016 Major IPOs Pipeline in Korea, we identified 19 companies that are seeking to complete IPOs in Korea in 2016. In this...
Douglas Kim
Follow
232 Views
Share
bullish
•
Thematic (Sector/Industry)
•
12 Feb 2016 23:11
2016 Major IPOs Pipeline in Korea
This year appears to be an exciting year for IPOs in Korea, barring a dramatic downturn in global equities markets like the one we experienced in...
Douglas Kim
Follow
289 Views
Share
bearish
•
Celltrion Inc
•
11 Oct 2015 04:02
The Risks of High Expectations for Biosimilars
Celltrion trades at a premium valuation (35x 2016 estimated earnings) based on high expectations for its biosimilar (copycats of biotech) products....
Kemp Dolliver, CFA
254 Views
Share
bullish
•
Thematic (Sector/Industry)
•
05 Feb 2015 16:01
Introducing Long Term Leaders - Focussed Insights for your Core Holdings
We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category, we have identified companies that...
Sumeet Singh
Follow
313 Views
Share
bullish
•
KT&G Corporation
•
03 Oct 2023 00:27
Alpha Generation Through Share Buybacks in Korea: August & September 2023
In this insight, we discuss the alpha generation through companies that announced share buybacks in Korea in August and September 2023.
Douglas Kim
Follow
598 Views
Share
First
Previous
92
93
94
95
96
97
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x